belatacept

A Study of TCD601 in de Novo Renal Transplant Recipients

Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy

Carfilzomib and Belatacept for Desensitization

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

Advancing Transplantation Outcomes in Children

Tolerance by Engaging Antigen During Cellular Homeostasis

Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO>

A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Daratumumab and Belatacept for Desensitization

Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression

Belatacept in De Novo Heart Transplantation

Abatacept Conversion in Kidney Transplantation

Belatacept in Heart Transplantation

Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.

A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Treg Modulation With CD28 and IL-6 Receptor Antagonists

Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination

Belatacept 3 Month Post Transplant Conversion Study

Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)

Precision Medicine Offers Belatacept Monotherapy